Services



Nutraceutical Products



Search Knowledge Base



TeleClasses & Events




The Cancer Coach



Subscribe to
     Morph2Health




Home
    
Dr. James partners with persons with cancers and other serious illnesses to construct a "whole person" roadmap leading to health and well-being. To immediately receive a free copy of my groundbreaking book, Conquer Your Fear of Cancer, click here now to sign up for a free homepage.




Behavioral Oncology Definitions -> Autologous Communications: The Autocrine/Paracrine Languages -> Lipid peroxidation is associated with the inhibitory action of all-trans-retinoic acid on mammary cell transformation.

Lipid peroxidation is associated with the inhibitory action of all-trans-retinoic acid on mammary cell transformation.

BACKGROUND: Retinoids are effective in reducing transformation of various cell types; however the role of lipid peroxidation has not been studied in this regard. MATERIALS AND METHODS: Retinoic acid (RA) and retinol were tested on several SV-40 large-T-antigen transformed bovine mammary fibroblast (MFB) lines that form foci on plastic with long-term culture. RESULTS: Dose response studies revealed that RA at 10(-6) M was the most potent dose in delaying the onset of foci formation and reducing total foci number. RA was always more effective than retinol. Addition of RA (10(-6) M) to MFB cells increased lipid peroxide (LPO) concentrations by approximately three-fold relative to untreated MFB cells or to RA or control treated normal mammary fibroblasts. The lipoxygenase inhibitor, nordihydroguaiaretic acid (NDGA), acted synergistically with RA to increase LPO and cell death in MFB cells. The combination of the cyclooxygenase inhibitor, indomethacin, at 10(-4) M with 10(-6) M RA lowered MFB fibroblast cell numbers when compared to fibroblasts cultured singly with either RA or indomethacin. CONCLUSIONS: These data indicate that an increase in lipid peroxidation occurs specifically in tumor cells treated with RA and this may play a role in RA-mediated suppression of cellular transformation in the mammary gland. Additionally, eicosanoid inhibitors may have an additive or synergistic effect with RA on the inhibition of mammary tumor cell transformation and proliferation.

Kubow S, Woodward TL, Turner JD, Nicodemo A, Long E, Zhao X.

School of Dietetics and Human Nutrition, McGill University, Ste. Anne de Bellevue, Quebec, Canada. Kubow@agradm.lan.mcgill.ca

PMID: 10810364[PubMed Citation]



Homepage | About ATO | Contact ATO | Privacy Policy | Terms and Conditions
Send Questions or Comments to info@james-arond-thomas.com
Contact Dr. James Today: (734) 973-8700.

© 2001-2006 James A. Arond-Thomas, M.D. All Rights Reserved. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Arond-Thomas is required.

Disclaimer: The entire contents of this website are based upon the opinions of Dr. Arond-Thomas, unless otherwise noted. Individual articles are based upon the opinions of the respective author, who retains copyright as marked. The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Arond-Thomas and his community. Dr. Arond-Thomas encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.
Arond-Thomas Online Sitemap